stockportfolio.pro
EHC vs HSIC: Which Stock Is the Better Buy?
Encompass Health Corporation and Henry Schein, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — EHC vs HSIC, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Encompass Health Corporation (EHC) | Henry Schein, Inc. (HSIC) | |
|---|---|---|
| Market cap | $10.1B | $9.8B |
| Revenue (latest FY) | $5.94B | $13.18B |
| Net income (latest FY) | $566.20M | $398.00M |
| Revenue growth (5y CAGR) | 10.7% | 5.4% |
| Net margin | 9.5% | 3.0% |
| Return on equity | 23.2% | 12.3% |
| P/E ratio | 17.5 | 26.1 |
| Dividend yield | 0.7% | — |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
See the full EHC vs HSIC breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open EHC's full financials → Open HSIC's full financials →More comparisons
Frequently asked questions
Which is bigger, EHC or HSIC?
Encompass Health Corporation is larger by market capitalization — $10.1B versus $9.8B.
Which grows faster, EHC or HSIC?
Over the last five fiscal years, Encompass Health Corporation grew revenue faster — 10.7%/yr versus 5.4%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
EHC fundamentals → · HSIC fundamentals → · All 1,500+ companies → · Free screener →